Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum
The Readout Loud
00:00
Biotec Stocks
Biotec stocks, and specifically how they are bad and seem to just get worse at em. The industry crossed a threshold this week. We'll be talking specificaly about a company cald dan carta later on the pies.
Transcript
Play full episode
